[{"NetIncomeLoss_3_Q3_USD":-18913000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-66203000.0,"IncomeTaxesPaid_3_Q3_USD":4878000.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q3_USD":5003000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":-13110000.0,"InventoryFinishedGoods_0_Q3_USD":18110000.0,"InterestPaidNet_3_Q3_USD":5080000.0,"TreasuryStockCommonShares_0_Q3_shares":75518.0,"AccruedLiabilitiesCurrent_0_Q3_USD":2534000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q3_USD":35249000.0,"AccruedRoyaltiesCurrent_0_Q3_USD":6088000.0,"InventoryGross_0_Q3_USD":65350000.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"OperatingLeaseLiability_0_Q3_USD":430000.0,"TreasuryStockCommonValue_0_Q3_USD":2246000.0,"Liabilities_0_Q3_USD":267481000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":249000.0,"Depreciation_3_Q3_USD":3500000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":17900000.0,"Depreciation_1_Q3_USD":1200000.0,"GoodwillImpairmentLoss_1_Q3_USD":0.0,"InterestExpenseDebtExcludingAmortization_1_Q3_USD":2351000.0,"InterestExpenseDebtExcludingAmortization_3_Q3_USD":6450000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_3_Q3_USD":449000.0,"InventoryValuationReserves_0_Q3_USD":6155000.0,"ResearchAndDevelopmentInProcess_3_Q3_USD":3753000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q3_shares":1100000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":1300000.0,"SellingGeneralAndAdministrativeExpense_1_Q3_USD":15725000.0,"SellingGeneralAndAdministrativeExpense_3_Q3_USD":50621000.0,"LongTermDebtCurrent_0_Q3_USD":12785000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1_Q3_shares":12000.0,"AssetsCurrent_0_Q3_USD":165819000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":61000.0,"InterestRateDerivativeLiabilitiesAtFairValue_0_Q3_USD":15971000.0,"InterestIncomeExpenseNonoperatingNet_1_Q3_USD":-2510000.0,"InterestIncomeExpenseNonoperatingNet_3_Q3_USD":-6898000.0,"GoodwillImpairmentLoss_3_Q3_USD":0.0,"StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_3_Q3_USD":0.0,"OtherAssetsNoncurrent_0_Q3_USD":985000.0,"AmortizationOfIntangibleAssets_1_Q3_USD":10100000.0,"AmortizationOfIntangibleAssets_3_Q3_USD":30200000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":-4667000.0,"AccountsReceivableNetCurrent_0_Q3_USD":83745000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":-229000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":-335000.0,"PrepaidExpenseCurrent_0_Q3_USD":3358000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":11953000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":12003000.0,"InterestCostsCapitalized_3_Q3_USD":100000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q3_USD":38655000.0,"EarningsPerShareBasic_1_Q3_USD":0.04,"EarningsPerShareBasic_3_Q3_USD":-1.58,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q3_USD":157050000.0,"IncreaseDecreaseInPrepaidExpense_3_Q3_USD":-637000.0,"InventoryRawMaterials_0_Q3_USD":43010000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":455000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":2939000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":12318000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":-371000.0,"NumberOfReportableSegments_3_Q3_segment":1.0,"CommonStockValue_0_Q3_USD":1000.0,"RepaymentsOfLinesOfCredit_3_Q3_USD":7500000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":-146000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":1373000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-27152000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q3_USD":422000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_3_Q3_USD":-18913000.0,"IncreaseDecreaseInInventories_3_Q3_USD":1151000.0,"CostsAndExpenses_1_Q3_USD":50177000.0,"CostsAndExpenses_3_Q3_USD":167570000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":132000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":769000.0,"EffectiveIncomeTaxRateContinuingOperations_3_Q3_pure":0.198,"ContractWithCustomerAssetNet_0_Q3_USD":100000.0,"DepreciationDepletionAndAmortization_1_Q3_USD":11358000.0,"DepreciationDepletionAndAmortization_3_Q3_USD":33739000.0,"InterestCostsCapitalizedAdjustment_1_Q3_USD":18000.0,"InterestCostsCapitalizedAdjustment_3_Q3_USD":67000.0,"TreasuryStockValueAcquiredCostMethod_3_Q3_USD":1523000.0,"ProceedsFromLinesOfCredit_3_Q3_USD":15000000.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q3_pure":0.198,"Assets_0_Q3_USD":462581000.0,"OtherComprehensiveIncomeLossNetOfTax_3_Q3_USD":-8239000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q3_USD":939000.0,"CostOfRevenue_3_Q3_USD":62617000.0,"InventoryWorkInProcess_0_Q3_USD":1086000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":11991000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":11953000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":20976000.0,"ValuationAllowancesAndReservesBalance_0_Q3_USD":86418000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":2383000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_3_Q3_USD":10543000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":63000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":-23580000.0,"Goodwill_0_Q3_USD":3580000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":16293000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q3_USD":34501000.0,"AmortizationOfFinancingCosts_1_Q3_USD":180000.0,"AmortizationOfFinancingCosts_3_Q3_USD":542000.0,"ContractWithCustomerLiabilityRevenueRecognized_3_Q3_USD":300000.0,"ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_3_Q3_USD":8700000.0,"CostOfRevenue_1_Q3_USD":20118000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":172000.0,"LiabilitiesCurrent_0_Q3_USD":75900000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_3_Q3_USD":-44458000.0,"NetIncomeLoss_1_Q3_USD":434000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":40444000.0,"CapitalExpendituresIncurredButNotYetPaid_3_Q3_USD":223000.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"FiniteLivedIntangibleAssetsNet_0_Q3_USD":198620000.0,"PaymentsToAcquireIntangibleAssets_3_Q3_USD":62178000.0,"AdditionalPaidInCapital_0_Q3_USD":211792000.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_1_Q3_USD":421000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q3_USD":31524000.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_3_Q3_USD":-18913000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q3_USD":198620000.0,"InterestExpenseDebt_1_Q3_USD":2513000.0,"InterestExpenseDebt_3_Q3_USD":6925000.0,"LongTermDebtNoncurrent_0_Q3_USD":175161000.0,"DeferredIncomeTaxesAndTaxCredits_3_Q3_USD":-9032000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":449000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":22903000.0,"AccountsPayableCurrent_0_Q3_USD":13460000.0,"RepaymentsOfOtherLongTermDebt_3_Q3_USD":5657000.0,"RetailRelatedInventoryPackagingAndOtherSupplies_0_Q3_USD":3144000.0,"EarningsPerShareDiluted_1_Q3_USD":0.04,"UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_1_Q3_USD":-12000.0,"OperatingLeaseCost_1_Q3_USD":57000.0,"OperatingLeaseCost_3_Q3_USD":166000.0,"PreferredStockValue_0_Q3_USD":0.0,"FiniteLivedIntangibleAssetsGross_0_Q3_USD":355670000.0,"ContractWithCustomerLiabilityCurrent_0_Q3_USD":112000.0,"InventoryNet_0_Q3_USD":59195000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_1_Q3_USD":939000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_3_Q3_USD":-8239000.0,"OperatingIncomeLoss_1_Q3_USD":2802000.0,"OperatingIncomeLoss_3_Q3_USD":-16347000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":52979000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":151223000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":25000.0,"UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted_1_Q3_USD":-13000.0,"DeferredIncomeTaxAssetsNet_0_Q3_USD":48130000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"ShareBasedCompensation_3_Q3_USD":10543000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":462581000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":5993000.0,"PreferredStockSharesAuthorized_0_Q3_shares":1666667.0,"DeferredTaxAssetsValuationAllowance_0_Q3_USD":400000.0,"AssetImpairmentCharges_1_Q3_USD":100000.0,"AssetImpairmentCharges_3_Q3_USD":104000.0,"IncreaseDecreaseInAccountsReceivable_3_Q3_USD":11616000.0,"LeaseCost_1_Q3_USD":72000.0,"LeaseCost_3_Q3_USD":210000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-1337000.0,"VariableLeaseCost_1_Q3_USD":15000.0,"VariableLeaseCost_3_Q3_USD":44000.0,"EarningsPerShareDiluted_3_Q3_USD":-1.58,"AmortizationOfFinancingCostsAndDiscounts_3_Q3_USD":1288000.0,"IncreaseDecreaseInIncomeTaxes_3_Q3_USD":-545000.0,"StockholdersEquity_0_Q3_USD":195100000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":16420000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q3_USD":9664000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":181000.0,"PropertyPlantAndEquipmentGross_0_Q3_USD":56737000.0,"ImpairmentOfIntangibleAssetsFinitelived_1_Q3_USD":0.0,"ImpairmentOfIntangibleAssetsFinitelived_3_Q3_USD":0.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":4025000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":59000.0,"Ticker":"ANIP","CIK":"1023024","name":"ANI PHARMACEUTICALS INC","OfficialName":"ANI Pharmaceuticals Inc.","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"3","uom":"USD","footnote":"nan","Market Cap":"569805985.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20201105"}]